| 1 | 105102-22-5 | 莫美达松 | Mometasone | C22H28Cl2O4 | |
| 2 | 122188-02-7 | 依托度酸甲酯 | Etodolac methyl ester | C18H23NO3 | 依托度酸中间体 |
| 3 | 304672-01-3 | 1-丙磺酸钠盐一水化物 | sodium propane-1-sulfonate hydrate | C3H7NaO3S | |
| 4 | 64491-70-9 | (R)-(-)环氧丙基甲基醚 | (R)-(-)-methylglycidyl ether | C4H8O2 | |
| 5 | 67580-39-6 | 9,10-二甲氧基蒽-2-磺酸钠盐 | 9,10-dimethoxyanthracene-2-sulfonic acid sodium salt | C16H13NaO5S | |
| 6 | 62625-30-3 | 溴甲酚紫钠盐 | BCP | C21H15Br2NaO5S | Study properties of silicon dioxide films |
| 7 | 837-08-1 | 2,4'-异亚丙基二苯酚 | o-[1-(4-hydroxyphenyl)-1-methylethyl]phenol | C15H16O2 | |
| 8 | 528851-31-2 | 脱乙烯环丙沙星盐酸盐 | DESETHYLENE CIPROFLOXACIN, HYDROCHLORIDE | C15H17ClFN3O3 | |
| 9 | 1071-71-2 | 6-氯-6-氧代己酸乙酯 (硫辛酸杂质) | ethyl 6-chloro-6-oxohexanoate | C8H13ClO3 | |
| 10 | 300-48-1 | (S)-2-氨基-3-(4-羟基-3-甲氧苯基)丙酸 | 3-METHOXY-L-TYROSINE | C10H13NO4 | |
| 11 | 50-86-2 | 4-乙酰氨基水杨酸 | 4-Acetamidosalicylic acid | C9H9NO4 | |
| 12 | 120568-11-8 | 5-[2-(4'-甲基联苯基)]四唑 | 5-[2-(4'-METHYLBIPHENYL)]TETRAZOLE | C14H12N4 | |
| 13 | 220771-03-9 | 2-氯甲基-3,5-二甲基-4-醇 | 2-Chloromethyl-3,5-dimethylpyridin-4-ol | C8H10ClNO | |
| 14 | 3213-30-7 | 3-羟基-4-甲氧基苯乙胺 | 3-hydroxy-4-methoxyphenethylamine | C9H13NO2 | |
| 15 | 154709-18-9 | 奥美沙坦酯杂质S | 5-[4'-Hydroxymethyl-(1,1'-biphenyl)-2-yl]-1-triphenylmethyltetrazole | C33H26N4O | |
| 16 | 487-26-3 | 黄烷酮 | FLAVANONE | C15H12O2 | |
| 17 | 60755-80-8 | O-去甲基加兰他敏 | O-DESMETHYLGALANTHAMINE | C16H19NO3 | |
| 18 | 6948-88-5 | 对萘酚苯指示剂 | ALPHA-NAPHTHOLBENZEIN | C27H18O2 | |
| 19 | 212321-78-3 | 去乙基达比加群酯 | BIBR 1087 SE | C32H37N7O5 | |
| 20 | 329216-63-9 | 喹硫平硫氧化物/喹硫平亚砜 | Quetiapine Sulfoxide | C21H25N3O3S | |
| 21 | 1202864-39-8 | 二甲酚橙二钠盐 | Xylenol Orange disodium salt | C31H32N2O13S | |
| 22 | 1516-08-1 | 氘代乙醇 | Ethanol-d6 | C2D6O | |
| 23 | 127780-16-9 | 泮托拉唑杂质A | Pantoprazole Sulfone | C16H14F2N3NaO5S | |
| 24 | 366793-17-1 | 二己基乙酸铵 | Dihexylammonium Acetate | C14H31NO2 | |
| 25 | 139755-85-4 | 5-(2-乙氧基-5-((4-(2-羟乙基)哌嗪-1-基)磺基)苯基)-1-甲基-3-丙基-1,6-二氢-7H-吡唑啉[4,3-d]嘧啶-7-酮 | 5-(2-Ethoxy-5-((4-(2-hydroxyethyl)piperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one | C23H32N6O5S | |
| 26 | 571186-93-1 | 伊马替尼杂质B | IMatinib related substance B | C29H31N7O3 | |
| 27 | 329216-67-3 | 2-(4-(二苯并[b,f][1,4]硫氮杂卓-11-基)哌嗪-1-基)乙醇 | 2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethanol | C19H21N3OS | |
| 28 | 59468-90-5 | 1-羟基咪达唑仑 | 1'-hydroxy Midazolam (Ro 21-6347) | C18H13ClFN3O | 1'-hydroxy Midazolam is the major metabolite of the anesthetic, midazolam. |
| 29 | 62572-94-5 | 4-[2-羟基-3-[(1-甲基乙基)氨基]丙氧基]-苯乙醇 | O-Desmethyl Metoprolol | C14H23NO3 | O-Desmethyl metoprolol is the major active metabolite of the β1-adrenergic receptor blocker metoprol |
| 30 | 95153-31-4 | (2S,3aS,7aS)-1-((S)-2-(((S)-1-羧基丁基)氨基)丙酰基)八氢-1H-吲哚-2-羧酸 (培哚普利杂质) | Perindoprilat (S-9780) | C17H28N2O5 | Perindoprilat is the active metabolite of perindopril, an inhibitor of angiotensin converting enzyme |
| 31 | 1530308-87-2 | 非布索坦杂质U | 2-(3-Cyano-4-propoxyphenyl)-4-methylthiazole-5-carboxylic acid | C15H14N2O3S | |
| 32 | 554-52-9 | 4-(2-氨基乙基)-2-甲氧基苯酚 | 4-(2-Aminoethyl)-2-methoxyphenol | C9H13NO2 | |
| 33 | 15917-65-4 | (Z)-2-(4-(1,2-二苯基丁-1-烯-1-基)苯氧基)-N-甲基乙胺盐酸盐 | (Z)-2-(4-(1,2-Diphenylbut-1-en-1-yl)phenoxy)-N-methylethanamine hydrochloride | C25H27NO | |
| 34 | 3086-44-0 | 3'-氨基-6'-羟基-3h-螺[2-苯并呋喃-1,9'-黄原胶]-3-酮 | Rhodol | C20H13NO4 | 高荧光染料，可用于标记寡核苷酸，抗体和蛋白质研究以及制备肽和酯酶底物。Rhodol是荧光素和罗丹明的结构混合物 |
| 35 | 99585-01-0 | 5-氯己酰氯 | 5-Chlorohexanoyl chloride | C6H10Cl2O | |
| 36 | 216453-74-6 | 布地奈德杂质L | 11-Keto Budesonide | C25H32O6 | |
| 37 | 1376614-99-1 | ENT-依折麦布 | ent-Ezetimibe | C24H21F2NO3 | |
| 38 | 302781-98-2 | 脱氟依泽替米贝 | Desfluoro-ezetimibe | C24H22FNO3 | |
| 39 | 444731-47-9 | 2-甲基-5-[[4-[甲基(3-甲基-1H-吲唑-6-基)氨基]-2-嘧啶基]氨基]-苯磺酰胺 | VEGFR-2-IN-6 | C20H21N7O2S | |
| 40 | 246512-44-7 | 2-氨基-4-甲氧基-5-(3-吗啉代丙氧基)苯甲酰胺 | Gefitinib impurity 2 | C15H23N3O4 | |
| 41 | 17689-42-8 | 2-((2-羟基乙氧基)羰基)苯甲酸 | 2-(2-hydroxyethoxycarbonyl)benzoic acid | C10H10O5 | |
| 42 | 3886-19-9 | 1-(2,6-二(苄氧基)苯基)乙酮 | 1-(2,6-Bis(Benzyloxy)Phenyl)Ethanone | C22H20O3 | |
| 43 | 945553-91-3 | (R,E)-N-(4-((3-氯-4-氟苯基)氨基)-7-((四氢呋喃-3-基)氧基)喹唑啉-6-基)-4-(二甲基氨基)丁-2-烯酰胺 | (R,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide | C24H25ClFN5O3 | |
| 44 | 268204-00-8 | 4-氨基-1-甲基-3-(2-甲基丙基)-1H-吡唑-5-甲酰胺 | 4-Amino-1-methyl-3-(2-methylpropyl)-1H-pyrazole-5-carboxamide | C9H16N4O | |
| 45 | 1677-29-8 | N1,N3-双(4-氟苯基)丙二酰胺 | N1,N3-Bis(4-fluorophenyl)malonamide | C15H12F2N2O2 | |
| 46 | 2631-61-0 | 3-(二甲基氨基)-1-(2-萘)-1-丙酮盐酸盐 | 3-(dimethylamino)-1-naphthalen-2-ylpropan-1-one,hydrochloride | C15H18ClNO | |
| 47 | 152402-97-6 | 4-氯-2-氯甲基-3-甲基吡啶盐酸盐 | 4-chloro-2-chloromethyl-3-methyl pyridine hydrochloride | C7H8Cl3N | |
| 48 | 212632-01-4 | 4-(4-(4-(4-羟基苯基)哌嗪-1-基)苯基)-1-(戊烷-3-基)-1H-1,2,4-三唑-5(4H)-酮 | 4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-1-(pentan-3-yl)-1H-1,2,4-triazol-5(4H)-one | C23H29N5O2 | |
| 49 | 152831-00-0 | 6-羟基苯溴马隆 | (3,5-dibromo-4-hydroxyphenyl)(2-ethyl-6-hydroxybenzofuran-3-yl)methanone | C17H12Br2O4 | |
| 50 | 864725-62-2 | 4-(5-(3,5-二氯苯基)-5-(三氟甲基)-4,5-二氢异噁唑-3-基)-2-甲基苯甲酸 | 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methylbenzoic acid | C18H12Cl2F3NO3 | |
| 51 | 1972612-60-4 | 贝达喹啉(1S,2S)异构体杂质3 | Bedaquiline (1S,2S) Isomer Impurity 3 | C32H31BrN2O2 | |
| 52 | 2223677-62-9 | (S,E)-N-(4-((3,4-二氟苯基)氨基)-7-((四氢呋喃-3-基)氧基)喹唑啉-6-基)-4-(二甲氨基)丁-2-烯酰胺(阿法替尼杂质) | Afatinib IMpurity SF | C24H25F2N5O3 | |
| 53 | 1027162-35-1 | 2-甲基-5-(2-(4-(甲基磺酰基)苯基)乙酰基)吡啶1-氧化物(依托考昔杂质) | Etoricoxib Impurity 18 | C15H15NO4S | |
| 54 | 2223677-63-0 | (S,E)-N-(4-((3,4-二氯苯基)氨基)-7-((四氢呋喃-3-基)氧基)喹唑啉-6-基)-4-(二甲氨基)丁-2- 烯酰胺(阿法替尼杂质) | Afatinib IMpurity SCl | C24H25Cl2N5O3 | |
| 55 | 856843-88-4 | 1,2-双(4-甲基哌嗪-1-基)乙酮(尼达尼布杂质) | Piperazine, 1-methyl-4-[(4-methyl-1-piperazinyl)acetyl]- (5CI) | C12H24N4O | |
| 56 | 2413212-13-0 | (S,E)-N-(4-((3-氯-4-氟苯基)氨基)-7-((四氢呋喃-3-基)氧基)喹唑啉-6-基)-4-(甲基氨基)丁-2-烯酰胺(阿法替尼杂质) | 2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(methylamino)-, (2E)- | C23H23ClFN5O3 | |
| 57 | 2413212-25-4 | 阿法替尼杂质18 | Afatinib Impurity 18 | C24H26FN5O3 | |
| 58 | 95093-99-5 | (R)-卡维地洛 | (R)-(+)-CARVEDILOL | C24H26N2O4 | |
| 59 | 127318-97-2 | 4-乙基-1,4,7,8-四氢-3H,10H-螺[吡喃并[3,4-f]吲哚嗪-6,2'-[1,3]二氧戊环] -3,10-二酮 | Spiro[1,3-dioxolane-2,6'(3'H)-[1H]pyrano[3,4-f]indolizine]-3',10'(4'H)-dione, 4'-ethyl-7',8'-dihydro- | C15H17NO5 | |
| 60 | 1269662-90-9 | 马来酸阿法替尼杂质杂质SM1-8-1 | N4-(3-chloro-4-fluorophenyl)-7-ethoxyquinazoline-4,6-diamine | C16H14ClFN4O | |
| 61 | 2223677-66-3 | (S)-N1-(4-((3-氯-4-氟苯基)氨基)-7-(((四氢呋喃-3-基)氧基)喹唑啉-6-基)-N2,N2-二甲基草酰胺(阿法替尼杂质) | Afatinib Impurity CSEJXA | C22H21ClFN5O4 | |
| 62 | 18891-13-9 | 己二酸甲乙酯 (硫辛酸杂质) | Hexanedioic acid 1-ethyl 6-methyl ester | | |
| 63 | 2568974-02-5 | 艾多沙班杂质1 | 2568974-02-5 | C23H25Cl2N7O5 | |
| 64 | 1682660-95-2 | 5-(2-硫氰酸乙酰基)噻吩-2-甲酰胺 | Thiocyanic acid, 2-[5-(aminocarbonyl)-2-thienyl]-2-oxoethyl ester | C8H6N2O2S2 | |
| 65 | 27415-25-4 | 8-异前列腺素 E2 | 8-ISO PROSTAGLANDIN E2 | C20H32O5 | |
| 66 | 1023594-50-4 | 4-(4-氨基-3-吡啶基)-1-哌嗪羧酸,1,1-二甲基乙酯 | 1-Piperazinecarboxylic acid, 4-(4-aMino-3-pyridinyl)-, 1,1-diMethylethyl ester | C14H22N4O2 | |
| 67 | 171596-28-4 | 他达拉非EP杂质C | cis-ent-Tadalafil | C22H19N3O4 | |
| 68 | 2475094-87-0 | (S,E)-N-(4-((4-氯-3-氟苯基)氨基)-7-((四氢呋喃-3-基)氧基)喹唑啉-6-基)-4-(二甲基氨基)但是- 2-烯酰胺 (阿法替尼杂质) | 2-Butenamide, N-[4-[(4-chloro-3-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-, (2E)- | C24H25ClFN5O3 | |
| 69 | 1987905-93-0 | 依鲁替尼杂质6 | Ibrutinib Impurity 6 | C47H46N12O3 | |
| 70 | 1912458-32-2 | 达比加群杂质G | Dabigatran iMpurity G | C24H29N5O4 | |
| 71 | 1917333-91-5 | (R)-8-(1-丙烯酰基哌啶-3-基)-10-(4-苯氧基苯基)-3,4-二氢吡唑并[4,3-e]嘧啶基[1,2-c]嘧啶-2(8H) -酮(伊布替尼/依鲁替尼杂质) | Ibrutinib Impurity 6 | C28H26N6O3 | |
| 72 | 1839099-22-7 | 伊布替尼杂质7 | (R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one | C25H26N6O2 | |
| 73 | 1830346-16-1 | 卡格列净杂质15 | 4-bromo-1-chloro-2-(2-ethoxybenzyl)benzene | C15H14BrClO | |
| 74 | 1821122-73-9 | 伊马替尼杂质72 | Imatinib Impurity 72 | C53H51N12O2 | |
| 75 | 1807642-39-2 | 沃诺拉赞杂质14 | 1H-Pyrrole-3-carbonitrile,5-(2-fluorophenyl)-1-(3-pyridinylsulfonyl)- | C16H10FN3O2S | |
| 76 | 1806469-15-7 | 5-(二氟甲氧基)-1H-苯并[d]咪唑-2-醇(泮托拉唑杂质) | Pantoprazole Impurity 5 | C8H6F2N2O2 | |
| 77 | 1702936-92-2 | 达比加群酯杂质H | Dabigatran Etexilate iMpurity H | C19H20N4O3 | |
| 78 | 1642630-12-3 | (S)-3-(4-苯氧基苯基)-1-(哌啶-3-基)-1H-吡唑并[3,4-d]嘧啶-4-胺(伊布替尼/依鲁替尼杂质) | (S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl) | C22H22N6O | |
| 79 | 1642853-67-5 | 达比加群杂质F | Dabigatran iMpurity F | C19H20N4O4 | |
| 80 | 1637254-93-3 | 阿法替尼杂质I | Afatinib IMpurity I | C22H19BrClFN4O3 | |
| 81 | 1627824-09-2 | 索非布韦杂质18 | (R)-isopropyl 2-(((R)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate | C18H17F5NO5P | |
| 82 | 1609405-34-6 | N-乙基他达拉非 | N-Ethyl Tadalafil | C23H21N3O4 | |
| 83 | 1580491-16-2 | 达比加群杂质K | Dabigatran iMpurity K | C32H38N8O4 | |
| 84 | 1456889-80-7 | 达比加群杂质E | Dabigatran iMpurity E | C20H22N4O3 | |
| 85 | 1456696-14-2 | (S,E)-4-(二甲氨基)-N-(4-羟基-7-((四氢呋喃-3-基)氧基)喹唑啉-6-基)丁-2-烯酰胺(阿法替尼杂质) | Afatinib IMpurity J | C18H22N4O4 | |
| 86 | 1408238-37-8 | 达比加群酯杂质F | Dabigatran Impurity p | C32H36N6O6 | |
| 87 | 1391053-95-4 | 西地那非杂质A | 5-[2-Ethoxy-5-[(4-Methyl-4-oxido-1-piperazinyl)sulfonyl]phenyl]-1,6-dihydro-1-Methyl-3-(2-Methylpropyl)-7H-pyrazolo[4,3-d]pyriMidin-7-one | C23H32N6O4S | |
| 88 | 1391068-25-9 | 盐酸利奈唑胺杂质D | Linezolid IMpurity D HCl | C15H23ClFN3O3 | |
| 89 | 1360430-70-1 | N-(3-氯-4-氟苯基)-7-乙氧基-6-硝基-4-喹唑啉胺 | N-(3-Chloro-4-fluorophenyl)-7-ethoxy-6-nitro-4-quinazolinamine | C16H12ClFN4O3 | |
| 90 | 1356020-01-3 | 阿莫西林杂质E | (4S)-2-[[[(2R)-2-AMino-2-(4-hydroxyphenyl)acetyl]aMino]Methyl]-5,5-diMethyl-4-thiazolidinecarboxylic Acid (Mixture of DiastereoMers) | C15H21N3O4S | |
| 91 | 1347262-29-6 | 奥美沙坦酯甲基酯 | OlMesartan Methyl Ester | C25H28N6O3 | |
| 92 | 1346602-67-2 | 西地那非二聚物杂质 | Sildenafil DiMer IMpurity | C38H46N10O8S2 | |
| 93 | 1296129-15-1 | 依折麦布四氢吡喃杂质(SCH59566) | (2R,3R,6S)-N,6-Bis(4-fluorophenyl)tetrahydro-2-(4-hydroxyphenyl)-2H-pyran-3-carboxaMide | C24H21F2NO3 | |
| 94 | 1288338-96-4 | (R)-1-(3-(4-氨基-3-(4-苯氧基苯基)-1H-吡唑并[3,4-d]嘧啶-1-基)哌啶-1-基)-3-氯丙烷-1 -酮(伊马替尼杂质) | (R)-1-[3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-3-chloropropan-1-one | C25H25ClN6O2 | |
| 95 | 1254702-87-8 | 明奈德 | Intermediate | C21H28NaO10P | |
| 96 | 1247859-37-5 | 1-((3-氟苯基)氨基甲酰基)环丙烷甲酸 (卡博替尼杂质) | Cabozantinib Impurity 46 | C11H10FNO3 | |
| 97 | 1245914-05-9 | 4-(5-氨基-3-吡啶基)-1-哌嗪羧酸，1,1-二甲基乙酯 | 1-Piperazinecarboxylic acid, 4-(5-aMino-3-pyridinyl)-, 1,1-diMethylethyl ester | C14H22N4O2 | |
| 98 | 1227380-90-6 | 埃索美拉唑进口标准杂质H431/41 | EsoMeprazole related substance H431/41 | C16H15N3O4 | |
| 99 | 1212376-05-0 | 替格瑞洛杂质89 | (1R)-2-chloro-1-(3,4-difluorophenyl)-1-ethanol | C8H7ClF2O | |
| 100 | 1184919-23-0 | 达沙替尼杂质 | Dasatinib iMpurity | C22H27N7O2S | |
| 101 | 1136478-30-2 | 5,6-脱氢普瑞巴林 | 5,6-Dehydropregabalin | C8H15NO2 | |
| 102 | 1111177-30-0 | 缬沙坦杂质Ⅱ | ethyl N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-N-pentanoyl-L-valinate | C26H33N5O3 | |
| 103 | 100777-46-6 | 1-氯-5-甲氧基-2-甲基-4-硝基苯 | 1-chloro-5-methoxy-2-methyl-4-nitrobenzene | C8H8ClNO3 | |
| 104 | 18514-52-8 | 2,3-二氨基-2-丁烯二腈 | 2,3-DIAMINOBUT-2-ENEDINITRILE | C4H4N4 | |
| 105 | 150322-06-8 | 3',6'-双(二甲基氨基)-3-氧代螺[异苯并呋喃-1(3H),9'-[9H]吨]-6-羧酸 | 6-TAMRA | C25H22N2O5 | |
| 106 | 145918-75-8 | 4-氨基-1-[(2S)-2-(羟甲基)-1,3-二氧杂环戊-4-基]嘧啶-2-酮 | TROXACITABINE | C8H11N3O4 | |
| 107 | 1092365-58-6 | (2Z)-4-(二甲基氨基)-2-丁烯酸(阿法替尼杂质) | Afatinib Impurity 56 | C6H11NO2 | |
| 108 | 19980-00-8 | (4-(羟甲基)哌啶-1-基)(苯基)甲酮 (艾氟康唑杂质) | [4-(hydroxymethyl)-1-piperidinyl]phenylMethanone | C13H17NO2 | |
| 109 | 132682-22-5 | S-2-恶唑烷酮-4-羧酸甲酯 | 4-Oxazolidinecarboxylicacid,2-oxo-,methylester,(4S)-(9CI) | C5H7NO4 | |
| 110 | 103876-98-8 | 埃索美拉唑有关物质 | 4-Hydroxy Omeprazole Sulfide | C16H17N3O2S | |
| 111 | 125656-82-8 | 奥美拉唑EP杂质F | Omeprazole EP Impurity F | C16H13N3O2S | |
| 112 | 131918-64-4 | 布地奈德EP杂质E | 14,15-Dehydro Budesonide | C25H32O6 | |
| 113 | 153012-65-8 | 布美他尼杂质D | PF 2825 | C21H28N2O5S | |
| 114 | 135308-74-6 | 氮氧双去甲基文拉法新 | D,L N,O-Didesmethylvenlafaxine | C15H23NO2 | |
| 115 | 170727-59-0 | 氯雷他定杂质E | Loratadine EP Impurity E | C22H23ClN2O2 | |
| 116 | 149456-97-3 | 艾拉莫德杂质10 | Iguratimod Impurity 10 | C18H20N2O6S | |
| 117 | 123662-92-0 | 艾拉莫德杂质2 | Iguratimod Impurity 2 | C18H16N2O6S | |
| 118 | 139755-91-2 | 西地那非杂质C | Desethyl Sildenafil | C20H26N6O4S | |
| 119 | 1079083-63-8 | 达格列净杂质23 | (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(4- hydroxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate | C27H29ClO10 | |
| 120 | 110104-37-5 | 阿昔洛韦杂质F | N2-ACETYL-9-[(2'-HYDROXYETHOXY)METHYL]GUANINE | C10H13N5O4 | |
| 121 | 185105-98-0 | 阿考替胺中间体1 | Acotiamide INT | C16H18N2O6S | |
| 122 | 162712-35-8 | 雷诺嗪杂质B | 1-Piperazineethanol, a-[(2-methoxyphenoxy)methyl]- | C14H22N2O3 | |
| 123 | 2223677-58-3 | 1-(4-((3-氯-4-氟苯基)氨基)-7-(((S)-四氢呋喃-3-基)氧基)喹唑啉-6-基)-5-羟基吡咯烷酮-2-酮(阿法替尼杂质) | Afatinib impurity 11/Des-(4-dimethylamino-2-en-1-oxo)butylamino 6-(5-Hydroxy-pyrrolidin-2-on-1-yl) Afatinib | C22H20ClFN4O4 | |
| 124 | 2170273-17-1 | (E)-N-(4-((3-氯-4-氟苯基)氨基)-7-氟喹唑啉-6-基)-4-(二甲基氨基)丁-2-烯酰胺(阿法替尼杂质) | Afatinib impurity 9 | C20H18ClF2N5O | |
| 125 | 2031255-26-0 | 依鲁替尼杂质15(伊布替尼/依鲁替尼杂质) | Ibrutinib Impurity 27 | C26H28N6O3 | |
| 126 | 2213398-75-3 | 依鲁替尼杂质28(伊布替尼/依鲁替尼杂质) | Ibrutinib Impurity 28 | C18H15N5O | |
| 127 | 2031255-23-7 | 依鲁替尼杂质9 | Ibrutinib Dimer Impurity | C50H48N12O4 | |
| 128 | 2101241-71-6 | 盐酸替吡嘧啶杂质2 | Tipiracil Impurity 2 | C9H10ClN3O3 | |
| 129 | 211914-96-4 | 达比加群杂质37 | Dabigatran Impurity 37 | C29H31N7O5 | |
| 130 | 2225986-95-6 | 达比加群酯杂质P | Dabigatran iMpurity K | C34H41N7O5 | |
| 131 | 355809-32-4 | 2-((4-氨基甲酰基苯基)氨基)乙酸(达比加群酯杂质) | Glycine, N-[4-(aminocarbonyl)phenyl]- | C9H10N2O3 | |
| 132 | 35592-96-2 | 3,4,5,6-四氯吡啶甲酸甲酯(瑞戈非尼杂质) | METHYL 3,4,5,6-TETRACHLOROPYRIDINE-2-CARBOXYLATE | C7H3Cl4NO2 | |
| 133 | 39084-88-3 | 丙胺卡因杂质A | IMp. A (EP): (RS)-2-Chloro-N-(2-Methylphenyl)-PropanaMide | C10H11Cl2NO | |
| 134 | 316149-01-6 | 依托考昔杂质10 | Etoricoxib Impurity 10 | C18H15ClN2OS | |
| 135 | 334951-61-0 | 尼达尼布I杂质 | Nintedanib impurity I | C30H31N5O4 | |
| 136 | 483-55-6 | 2-羟基-3-甲基-1,4-萘醌 | 2-hydroxy-3-methyl-1,4-naphthoquinone | C11H8O3 | |
| 137 | 402855-03-2 | 7-[(R)-(四氢呋喃-3-基)氧基]-N-(3-氯-4-氟苯基)-6-氨基-4-氨基喹唑啉 | 4,6-Quinazolinediamine, N4-(3-chloro-4-fluorophenyl)-7-[[(3R)-tetrahydro-3-furanyl]oxy]- | C18 H16 Cl F N4 O2 | |
| 138 | 433303-94-7 | 1-(苯并[b]噻吩-5-基)哌嗪(依匹哌唑杂质) | Brexpiprazole Impurity 76 | C12H14N2S | |
| 139 | 4504-96-5 | 多塞平杂质C | Doxepin Related Compound C (25 mg) ((E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride) | C18H20ClNO | |
| 140 | 56649-48-0 | 依托咪酯EP杂质A | (R)-(+)-1-(1-PHENYLETHYL)-1H-IMIDAZOLE-5-CARBOXYLIC ACID | C12H12N2O2 | |
| 141 | 5226-01-7 | 光甾醇 3 | Lumisterol 3 | C27H44O | |
| 142 | 579-21-5 | 山梗烷酮 | 2,2'-(1-Methyl-2,6-piperidinediyl)diacetophenon | C22H25NO2 | |
| 143 | 611226-36-9 | 4-羟基-2-(N-甲基)吡啶甲酰胺 | 2-Pyridinecarboxamide, 4-hydroxy-N-methyl- (9CI) | C7H8N2O2 | |
| 144 | 68257-89-6 | 5-乙酰基噻吩-2-甲酰氨 | 5-ACETYLTHIOPHENE-2-CARBOXAMIDE | C7H7NO2S | |
| 145 | 646459-39-4 | 依托考昔杂质 7 | Etoricoxib Impurity 7 | C20H21N3O2S | |
| 146 | 62580-80-7 | 奥硝唑 | 3-(2-methyl-5-nitroimidazole-1-yl)-1,2-propanediol | C7H11N3O4 | |
| 147 | 6144-78-1 | 索拉非尼杂质 | 2-Pyridinecarboxamide,N-methyl-(9CI) | C7H8N2O | |
| 148 | 68728-47-2 | 阿莫西林相关物质D | Amoxicillin Related Compound D (50 mg) ((4S)-2-{[(R)-2-amino-2-(4-hydroxyphenyl)acetamido](carboxy)methyl}-5,5-dimethylthiazolidine-4-carboxylic acid, monosodium salt) | C16H20N3NaO6S | |
| 149 | 722-97-4 | 5,5-二烯丙基-1,3-二甲基嘧啶-2,4,6(1H，3H，5H)-三酮(奥司他韦杂质) | 1,3-Dimethyl-5,5-diallylhexahydropyrimidine-2,4,6-trione | C12H16N2O3 | |
| 150 | 71748-58-8 | 4-酮13-顺式维甲酸 | 4-OXO-ISOTRETINOIN | C20H26O3 | |
| 151 | 7276-28-0 | FLUORESCEINDIPROPIONATE | FLUORESCEIN DIPROPIONATE | C26H20O7 | |
| 152 | 748707-58-6 | 卡博替尼杂质1 | Cabozantinib impurity 1 | C17H16N2O3 | |
| 153 | 71980-98-8 | 莫匹罗星EP杂质B | Pseudomonic acid C | C26H44O8 | |
| 154 | 74050-20-7 | 醋丙氢可的松 | Hydrocortisone | C26H36O7 | |
| 155 | 79925-38-5 | 非洛地平杂质C | NeMadipine B | C19H21Cl2NO4 | |
| 156 | 834919-19-6 | 依度沙班杂质EDBZP | (1S,3R,4S)-4-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-3-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexane-1-carboxylic acid | C22H25ClN6O5S | |
| 157 | 881676-90-0 | 沃诺拉赞杂质43 | 5-phenyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde | C16H12N2O3S | |
| 158 | 918642-61-2 | 1-((2-氟苯基)氨基甲酰基)环丙烷甲酸(卡博替尼杂质) | Cyclopropanecarboxylic acid, 1-[[(2-fluorophenyl)amino]carbonyl]- | C11H10FNO3 | |
| 159 | 915095-99-7 | 乙酰恩格列净 | Acetoxy Empagliflozin | C31H35ClO11 | |
| 160 | 95932-39-1 | 卡博替尼杂质4 | Cabozantinib impurity 4 | C11H15NO3 | |
| 161 | 90098-38-7 | 瑞巴派特甲酯 | Rebamipide Methyl Ester | C20H17ClN2O4 | |
| 162 | 91192-27-7 | 达比加群酯杂质43 | Glycine, N-(3-cyanophenyl)- | C9H8N2O2 | |
| 163 | 936563-97-2 | (S)-依鲁替尼 | (S)-Ibrutinib | C25H24N6O2 | |
| 164 | 2095256-87-2 | 酮康唑杂质17 | Ketoconazole Impurity 17 | | |
| 165 | 4876-16-8 | 4-(羟甲基)喹啉-2(1H)-酮 | 4-(hydroxymethyl)quinolin-2(1H)-one | C10H9NO2 | |
| 166 | 4876-17-9 | 4-(氯甲基)喹啉-2(1H)-酮 | 4-Chloromethyl-1H-quinolin-2-one | C10H8ClNO | |
| 167 | 127452-30-6 | 2-(6-(乙酰氨基甲基)-5-氧代-2,3-二氢-5H-螺[吲哚嗪-1,2'-[1,3]二氧戊环]-7-基)丁酸乙酯 | Spiro[1,3-dioxolane-2,1'(5'H)-indolizine]-7'-acetic acid, 6'-[(acetylamino)methyl]-α-ethyl-2',3'-dihydro-5'-oxo-, ethyl ester | C19H26N2O6 | |
| 168 | 654653-95-9 | (1R,2S)-1-(6-溴-2-甲氧基喹啉-3-基)-4-(二甲氨基)-2-(萘-2-基)-1-苯基丁-2-醇 | 3-Quinolineethanol, 6-bromo-α-[2-(dimethylamino)ethyl]-2-methoxy-α-2-naphthalenyl-β-phenyl-, (αR,βS)-rel- | C32H31BrN2O2 | |
| 169 | 654655-70-6 | 6-溴-2-乙氧基-3-(苯甲基)-喹啉 | Quinoline, 6-bromo-2-ethoxy-3-(phenylmethyl)- | C18H16BrNO | |
| 170 | 69676-24-0 | 5-甲基-2-(1-甲基乙氧基)苯胺 | 5-Methyl-2-propan-2-yloxyaniline | C10H15NO | |